Discovering value through integrated IT compliance programs - An introduction for pharmaceutical and life sciences companies

May 2017

Start adding items to your reading lists:
or
Save this item to:
This item has been saved to your reading list.


Making the case for an integrated IT compliance program

Traditionally, IT compliance within pharmaceutical and life sciences organizations has been viewed through discrete regulatory lenses such as Sarbanes-Oxley (SOX), GxP (Quality), information security, and data privacy. This has often led to a decentralized approach prone to risk management gaps, control redundancies, inefficient allocation of resources, and fewer opportunities for synergies. This report discusses the benefits pharmaceutical and life sciences organizations can realize by shifting from decentralized controls and monitoring functions to an integrated IT compliance framework and monitoring organization. 

 

Share

Realizing value by shifting from a decentralized to an integrated approach

An integrated and centralized IT compliance framework combines applicable compliance and regulatory controls into a single set of objectives. Having standard controls, a single assessment methodology, and common reporting tools across an organization can increase transparency and accountability.

Pharmaceutical and life sciences have experienced benefits such as:

  • Decreased compliance risk as a result of a centralized compliance function which enhances coordination and communication across
    the organization
  • Time and cost savings through the reduction of duplicate controls and alignment of compliance activities and assessments
  • Better understanding of risk and controls through a common dialogue and control set

Contact us

Craig Cleaver
US Pharmaceutical and Life Sciences Risk Assurance Leader
Tel: +1 (267) 330 2908
Email

Tiffany-Anne Gallagher
Principal, Risk Assurance Pharmaceutical & Life Sciences
Tel: +1 (551) 655 4573
Email

Follow us